LONDON--(BUSINESS WIRE)--The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023. This market report provides a detailed analysis of the market by product ...
Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...
The albuterol sulfate MDIs market sees opportunities in eco-friendly inhaler development, generic inhalers, and ...
Hosted on MSN
Finding the right asthma inhaler for you
New triple therapy: The FDA approved AstraZeneca’s Breztri Aerosphere for asthma patients 12 and older, offering a single inhaler combining ICS/LABA with a LAMA for maintenance treatment. Device ...
The US Food and Drug Administration (FDA) on Wednesday published a revised draft guidance on metered dose inhalers (MDIs) and dry powder inhalers (DPIs), offering recommendations on chemistry, ...
Please provide your email address to receive an email when new articles are posted on . Tailored metered-dose inhaler education was more effective compared with brief intervention for improving asthma ...
Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler declined slightly over the past decade, but an increase in annual prescription ...
Advair (fluticasone propionate/salmeterol) is a brand-name drug prescribed for asthma and chronic obstructive pulmonary disease (COPD) in adults and some children. Advair comes in two versions, each ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
Spiriva (tiotropium bromide) is a prescription drug that’s used to treat COPD and asthma. The drug comes in an inhaler. It’s usually used once per day. Spiriva is a prescription drug that comes in two ...
Inhalers prescribed to Centers for Medicare & Medicaid Services (CMS) beneficiaries for asthma and chronic obstructive pulmonary disease resulted in estimated emissions of greenhouse gases equivalent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results